Cargando…
Anagrelide-Induced Supraventricular Tachycardia: A Case Report
Anagrelide is an inhibitor of the phosphodiesterase-3 (PDE-3) enzyme that suppresses megakaryocytes; hence it is used in the treatment of essential thrombocythemia. Anagrelide can cause positive inotropic and chronotropic effects on the cardiovascular system. Its cardiovascular side effects are rare...
Autores principales: | Badar, Faraz, Azeez, Hayder, Abdulrahman, Zeinab, Ashraf, Aqsa, Iftikhar, Asma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213328/ https://www.ncbi.nlm.nih.gov/pubmed/35747119 http://dx.doi.org/10.7759/cureus.26119 |
Ejemplares similares
-
Supraventricular Tachycardia and Tricuspid Regurgitation in the Setting of Misplaced Implantable Port Catheter Tip
por: Awan, Ahmad, et al.
Publicado: (2017) -
Paroxysmal Supraventricular Tachycardia
por: Arnold, Casey, et al.
Publicado: (2019) -
Efficacy of Adenosine Versus Verapamil in Terminating Acute Attacks of Paroxysmal Supraventricular Tachycardia: A Systematic Review
por: Pachchipulusu, Vamsi Krishna, et al.
Publicado: (2023) -
A Peculiar Case of Fentanyl-Induced Cardiomyopathy
por: Badar, Faraz, et al.
Publicado: (2022) -
Paroxysmal Supraventricular Tachycardia and Cardiac Arrest: A Presentation of Pulmonary Embolism With Infarction as a Sequela of Long COVID Syndrome
por: Talwar, Dhruv, et al.
Publicado: (2021)